https://mindmedicinelaw.com/briefing/mdma-study-with-psychoanalytic-psychotherapists-new-insights-20260618-14548The Psychedelic Journalen2026-06-19T22:06:54.750143+00:00MDMA Study with Psychoanalytic Psychotherapists: New InsightsMDMA-assisted psychotherapy, psychoanalytic psychotherapists, psychological mechanisms, qualitative study, psychedelic therapy, PTSD treatmenthttps://mindmedicinelaw.com/briefing/psilocin-distribution-in-zebrafish-implications-for-safety-20260618-14547The Psychedelic Journalen2026-06-19T22:06:44.458274+00:00Psilocin Distribution in Zebrafish: Implications for Safetypsilocin distribution, zebrafish model, DESI-MSI, neurobehavioral effects, psychedelic safety, psilocybin research, drug distribution mapping, clinical implications, psychedelic policy, toxicology studieshttps://mindmedicinelaw.com/briefing/lsd-s-impact-on-motor-learning-and-stress-new-clinical-insights-20260618-14528The Psychedelic Journalen2026-06-19T22:06:24.034801+00:00LSD's Impact on Motor Learning and Stress: New Clinical InsightsLSD, motor learning, stress reduction, neuroplasticity, psychedelic research, clinical trials, cognitive flexibility, neurophysiological effects, long-term potentiation, therapeutic applicationshttps://mindmedicinelaw.com/briefing/psychedelic-healing-initiative-for-system-impacted-individuals-20260618-14320The Psychedelic Journalen2026-06-18T22:04:06.073895+00:00Psychedelic Healing Initiative for System-Impacted Individualspsychedelic-assisted healing, system-impacted individuals, marginalized communities, policy reform, public health, clinical trials, psilocybin, MDMA, equity in research, therapeutic potentialhttps://mindmedicinelaw.com/briefing/mental-health-professionals-views-on-psychedelics-for-sud-20260617-14529The Psychedelic Journalen2026-06-19T22:07:10.766524+00:00Mental Health Professionals' Views on Psychedelics for SUDpsychedelic-assisted therapy, substance use disorders, mental healthcare professionals, education and training, clinical integration, safety concernshttps://mindmedicinelaw.com/briefing/schizophrenia-gene-ensemble-and-decision-noise-new-insights-20260617-14562The Psychedelic Journalen2026-06-19T22:07:03.373726+00:00Schizophrenia Gene Ensemble and Decision Noise: New Insightsschizophrenia, prefrontal neuron ensemble, decision noise, pharmacological strategy, NMDA receptor, clozapine, multi-receptor antagonist, precision medicine, mental health treatment, psychiatric disordershttps://mindmedicinelaw.com/briefing/ibogaine-mortality-risk-new-study-analyzes-19-071-patients-20260617-14559The Psychedelic Journalen2026-06-19T22:06:34.170589+00:00Ibogaine Mortality Risk: New Study Analyzes 19,071 Patientsibogaine, mortality risk, psychedelic treatment, clinical protocols, safety standards, regulatory perspectives, addiction treatment, psychoactive substances, neuroscience, public healthhttps://mindmedicinelaw.com/briefing/durable-change-framework-in-psychiatry-implications-for-trials-20260617-14083The Psychedelic Journalen2026-06-18T15:04:51.772159+00:00Durable Change Framework in Psychiatry: Implications for Trialspsychiatric treatment, high-plasticity brain states, clinical trial design, psychedelic-assisted therapy, brain plasticity, durable psychological change, critical periods, transcranial magnetic stimulation, deep brain stimulation, treatment efficacyhttps://mindmedicinelaw.com/briefing/community-driven-psilocybin-therapy-study-in-new-mexico-20260617-14046The Psychedelic Journalen2026-06-18T15:04:39.160785+00:00Community-Driven Psilocybin Therapy Study in New Mexicopsilocybin therapy, community engagement, PTSD treatment, New Mexico, equitable access, economic analysis, clinical trials, psychedelic research, mental health, policy implicationshttps://mindmedicinelaw.com/briefing/youth-addiction-interventions-insights-and-challenges-20260616-14066The Psychedelic Journalen2026-06-18T15:05:01.743051+00:00Youth Addiction Interventions: Insights and Challengesyouth addiction interventions, substance addiction, behavioral addiction, children and adolescents, psychotherapy, educational interventions, public health, addiction research, early intervention, stakeholder collaboration